1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Veterinary Vaccines Market – By Vaccine Type

1.3.2        North America Veterinary Vaccines Market – By Technology

1.3.3        North America Veterinary Vaccines Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Veterinary Vaccines Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Veterinary Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Growing Incidences of Zoonotic Diseases

5.1.2        Accelerating Prevalence of Foodborne Diseases and Infections

5.2         Market Restraints

5.2.1        Stringent Government Rules Related to Usage of Veterinary Vaccines

5.3         Market Opportunities

5.3.1        Burgeoning Growth in Untapped Economies

5.4         Future Trends

5.4.1        Growing Awareness of Diagnosis and Treatment of Variety of Infectious Diseases

5.5         Impact Analysis

6.           Veterinary Vaccines Market– North America Analysis

6.1         North America Veterinary Vaccines Market Revenue Forecast and Analysis

7.           North America Veterinary Vaccines Market Revenue and Forecasts to 2028– By Vaccine Type

7.1         Overview

7.2         North America Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)

7.3         Livestock Vaccines

7.3.1        Overview

7.3.2        Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.3.3        Bovine Vaccines

7.3.3.1          Overview

7.3.3.2          Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.3.4        Small Ruminant Vaccines

7.3.4.1          Overview

7.3.4.2          Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Companion Vaccines

7.4.1        Overview

7.4.2        Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3        Feline Vaccines

7.4.3.1          Overview

7.4.3.2          Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4        Canine Vaccines

7.4.4.1          Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5        Other Companion Animal Vaccines

7.4.5.1          Overview

7.4.5.2          Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.5         Others:

7.5.1        Overview

7.5.2        Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Veterinary Vaccines Market Revenue and Forecasts to 2028 – By Technology

8.1         Overview

8.2         North America Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)

8.3         Live Attenuated Vaccines

8.3.1        Overview

8.3.2        Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.4         Inactivated Vaccines

8.4.1        Overview

8.4.2        Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.5         Toxoid Vaccines

8.5.1        Overview

8.5.2        Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.6         Recombinant Vaccines

8.6.1        Overview

8.6.2        Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.7         Others

8.7.1        Overview

8.7.2        Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

9.           North America Veterinary Vaccines Market Revenue and Forecasts to 2028 – Country Analysis

9.1         North America: Veterinary Vaccines Market

9.1.1        Overview

9.1.3        North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)

9.1.3.1          US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.1          US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.1.2          US: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)

9.1.3.1.2.1        US: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)

9.1.3.1.2.2        US: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)

9.1.3.1.3          US: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)

9.1.3.2          Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.1          Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.2.2          Canada: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)

9.1.3.2.2.1        Canada: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)

9.1.3.2.2.2        Canada: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)

9.1.3.2.3          Canada: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)

9.1.3.3          Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.1          Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.1.3.3.2          Mexico: Veterinary Vaccines Market, Vaccine Type, 2019–2028 (US$ Million)

9.1.3.3.2.1        Mexico: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (US$ Million)

9.1.3.3.2.2        Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines, 2019–2028 (US$ Million)

9.1.3.3.3          Mexico: Veterinary Vaccines Market, by Technology, 2019–2028 (US$ Million)

10.        Impact of COVID-19 Pandemic on North America Veterinary Vaccines Market

10.1      North America: Impact Assessment of COVID-19 Pandemic

11.        Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Boehringer Ingelheim International GmbH

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Zoetis Inc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Merck & Co., Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Virbac

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      BIOVAC

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      NEOGEN Corporation

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Elanco

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      HIPRA

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Ceva

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             North America Veterinary Vaccines Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2.             US Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Veterinary Vaccines Market, by Companion Animal Vaccines– Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Canada: Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada: Veterinary Vaccines Market, by Companion Animal Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Mexico: Veterinary Vaccines Market, Vaccine Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Mexico: Veterinary Vaccines Market, by Livestock Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico: Veterinary Vaccines Market, by Companion Animal Vaccines – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Veterinary Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Veterinary Vaccines Market Segmentation

Figure 2.           North America Veterinary Vaccines Market, By Country

Figure 3.           North America Veterinary Vaccines Market Overview

Figure 4.           Livestock Vaccines Segment Held the Largest Share of the Market in 2021

Figure 5.           The US is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints Pertaining to North America Veterinary Vaccines Market

Figure 9.           North America Veterinary Vaccines Market – Forecast and Analysis to 2028

Figure 10.        North America Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)

Figure 11.        North America Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        North America Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        North America Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        North America Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        North America Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        North America Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        North America Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        North America Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)

Figure 20.        North America Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21.        North America Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22.        North America Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23.        North America Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24.        North America Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25.        North America: Veterinary Vaccines Market, by Key Country – Revenue (2021) (US$ Million)

Figure 26.        North America: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)

Figure 27.        US: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Canada: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Mexico: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in North American Country Markets

CONTACT US

If you have any queries about this report or would like further information, please contact us:

North America:            +1 646 491 9876

Asia-Pacific:                +91 20 6727 8686

Email:                          info@theinsightpartners.com

DISCLAIMER

All Rights Reserved.

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.